Immutep Limited (IMMP)

Immutep stock forecast: buy or sell

Immutep stock outlook

  • Immutep stock just moved 0% to close at $1.31 on the stock market last Friday.
  • Price is drawing a scaled uptrend since late March with higher tops and higher bottoms. Up to date, price made a 147.17% gain since the beginning of this rally
  • Immutep Limited, a biotechnology company, engages in the research, development, and commercialization of biological products.
No ad for you

Important note:
The opinions expressed in this post are personal and not recommendations for you to buy or sell shares. The author of this paper does not have an understanding of the specific conditions of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Comments are expressed for informational reasons only

Immutep stock chart overview

Should I buy Immutep stock?

All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best

Is IMMP stock a buy?

Currently, Immutep stock matches one trading strategy:

Uptrend buy setup

Immutep stock continues to trend higher since in late March and has marked an amazing 147.17% gain. Price marked a pull back in this uptrend at $1.25 on August 3, and since then it bounced off a 4.8%. Breaking out above $1.95 - it's last top - will be a good entry point if Immutep resumes the uptrend. If you decide to enter this trade, the suggested stop loss is at $1.76

Buy setupBuy pointStop lossRisk
Uptrend buy setup$1.95$1.7610%
No ad for you

Should I sell Immutep stock?

When you own a stock with some profit, it's really difficult to decide the best moment to sell and get your benefits. Trading strategies let us to avoid rash decisions based on our emotions or the buzz that surrounds the market. Our trading system selects very simple strategies to guide us on when is a good moment to sell a stock. Be aware that these strategies are not intended for shorting IMMP stock

A golden rule is that you should never mantain a trading operation that produces higher than expected losses at the time of the buy. The timing to sell shares should always be ruled by the stop-loss (automatic or manual)

Is it time to sell Immutep stock?

In the current situation of Immutep there is not any eligible sell setup, so Immutep stock holders with operations in green can keep their positions

No ad for you

Analysts' recommendations to buy or sell Immutep stock

Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal

We don't have any rating published in the last month for Immutep

No ad for you

Technical analysis

Immutep shares started an uptrend in late March, and gained a gorgeous 147.17%. During this uptrend, the price offered some entry points on the breakouts. Latest low was on August 3, when price bounced at $1.25. Like in all uptrends, price needs to rest and currently price is moving in a range between $1.95 and $1.25

SMAs overview

A favorite tool of many traders are the moving averages, that easily show trend direction. A moving average is the average price of a stock over a set period of time. Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days. Further about Moving Averages from sources like Wikipedia and Investopedia

Supports and resistances

Investors use support and resistance levels to find price points in the stock price action that tend to act as obstacles, preventing the price of an asset to move up or down. A support level is a level where the price may stop as it falls. Price is more likely to "rebound" this level rather than break through it. However, if the price breaks down this level, it will probably continue descending until approaching another support level. On the contrary, resistance levels are where the price may find opposition as it rises. Likewise, the price is more likely to "bounce off" at this level, and if it finally breaches this level, the price will rally easily until it hits the next resistance

The current resistance levels are:

  • R1: $1.37 (4.58% above)
  • R2: $1.40 (6.87% above)
  • R3: $1.42 (8.4% above)
  • The current support levels are:

  • S1: $1.27 (-3.05% below)
  • S2: $1.25 (-4.58% below)
  • S3: $1.03 (-21.37% below)
  • Bollinger bands

    This is an indicator that was developed in the 1980s by John Bollinger. By essence, the Bollinger Bands are bands that run around a centralmoving average, varying the distance from the bottom to the top depending on market volatility. They are usually drawn by an interval of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20

    Relative strength index

    The relative strength index (RSI) is a technical indicator used in the analysis of stock markets. It is intended to map the current and previous weakness or strength of a stock or market based on the closing prices of a recent trading period. Oscillator indicators, such as relative strength, are intended to indicate values in the range of 0-100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978

    The RSI dropped below the overbought level of 70 in mid-July after just crossing to the overbough zone for just one day (weak signal). The RSI value last Friday was 51.87. Immutep stock dropped a 7.75% since that level was lost

    No ad for you

    Earnings and financials

    Immutep Limited (IMMP) came out with quarterly earnings of $0.00 per share, meeting the analysts consensus estimate of $0.00 per share. The company said turnover was $0.00 consistent with analysts' forecasts as well.

    In contract, the EPS for the same quarter last year was $0.00, so current EPS is -. Sales skyrocketed a 2641.51% on an annualized basis in the first-quarter, from $1,750,520 to $4.8M last quarter.

    Immutep is presenting earnings report on Wednesday next week. Expected earnings of %s per-share for this quarter is $0.00. Earnings reporting day has an additional risk for stock investors as the information provided can gap up or down the price with very low volume and not respecting your buy/stop-loss orders. You can find more details about the earnings call and the earnings reports on the Investor Relations section of its website: http://www.immutep.com.

    No ad for you